Heart Failure Flashcards

1
Q

A complex syndrome leading to impaired ventricular filling or blood ejection

A

Heart Failure

HF may be caused by structural abnormalities of the pericardium, myocardium, endocardium, heart valves, or great vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HF leads to ______

A

Systemic hypoperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are common symptoms of heart failure?

A
  • Fatigue
  • Dyspnea
  • Weakness
  • Edema
  • Weight gain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define HF with reduced EF (HFrEF) aka _____.

A

HF w/ EF ≤ 40% aka Systolic HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define HF with preserved EF (HFpEF). aka_____

A

HF w/ EF ≥ 50% aka diastolic HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is borderline HFpEF?

A

Symptomatic HF w/ an EF between 40-49%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What type of dysfunction is present in both HFrEF and HFpEF?

A

Diastolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What distinguishes HFrEF from HFpEF?

A
  • LV dilation patterns
  • Remodeling
  • Different responses to medical treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

_____ measured on ____ is the main marker for determining HF risk factors, treatment, and outcomes?

A

Ejection fraction, measured on echocardiogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is normal EF?

A

> 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What proportion of HF patients have a normal ejection fraction?

A

Approximately 1/2 of HF patients have normal (>50%) ejection fraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List some conditions associated with the increasing proportion of HFpEF.

A
  • Hypertension
  • Diabetes Mellitus
  • Atrial fibrillation
  • Obesity
  • Metabolic syndrome
  • Chronic obstructive pulmonary disease (COPD)
  • Renal insufficiency
  • Anemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What type of risk factors are more likely in patients with HFrEF?

A
  • Modifiable risk factors (smoking, hyperlipidemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pt’s with HFrEF have higher incidence of:

A
  • Higher incidence of myocardial ischemia & infarction
  • Previous coronary intervention
  • CABG
  • Peripheral vascular disease (PVD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What percentage of HF cases are classified as HFpEF?

A

52%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What percentage of HF cases are classified as HFrEF?

A

33%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What percentage of HF cases are classified as borderline HFpEF?

A

16%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Who is more likely to be affected by HFpEF?

A

Women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Who is more likely to be affected by HFrEF?

A

Men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the primary determinant of HFpEF?

A

Left ventricular diastolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the primary determinant of HFrEF?

A

Left ventricular systolic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What factors determine the LV’s ability to fill?

A
  • Pulmonary venous blood flow
  • Left atrial (LA) function
  • Mitral valve dynamics
  • Pericardial restraint
  • Elastic properties of the left ventricle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The majority of LVDD depends on: (3)

A
  1. HR
  2. Loading conditions
  3. Contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What does a steeper rise of the end-diastolic pressure-volume curve indicate?

A

Delayed LV relaxation and increased myocardial stiffness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Reduced LV compliance leads to: (4)

A
  1. LA HTN
  2. LA dysfunction
  3. Pulmonary venous congestion
  4. Exercise intolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

In HFrEF, what is seen on the flow-volume loop?

A

Decreased contractility shown in the decreased slope of the ESPVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

In HFpEF, what is seen on the flow-volume loop?

A

Decreased LV compliance is seen by an increase in the EDPVR slope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is the age demographic of a patient with LVDD?

A

Age > 60 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

In LVEDD - The delay in relaxation is caused by failure of ______________, that occurs due to inadequate perfusion or dysfunctional ________ homeostasis

A

Failure of Actin-myosin disassociation
Dysfunctional Intracellular Ca++

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What determines LV relaxation?

A

Afterload (usually elevated in HTN patients)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What can exacerbate diastolic dysfunction?

A

Tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What occurs in HFpEF even though there is only a slight depression in LV systolic dysfunction?

A

Exercise intolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Prolonged _____ _____ restricts diastolic blood flow, contributing to sub-endocardial ischemia and further decreasing exercise tolerance

A

Prolonged coronary compression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are common symptoms in HFpEF?

A
  • Paroxysmal nocturnal dyspnea
  • Pulmonary edema
  • Dependent edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What heart sound is more common in HFrEF?

A

S3 gallop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What establishes the diagnosis of HFrEF in addition to the definitions?

A

Reduced EF + Presence of HF symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Which type of HF is harder to Dx due to little symptoms at rest?

A

HFpEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What diagnostic tool defines elevated LV systolic and diastolic stiffness?

A

Cardiac catheterization using pressure-volume analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What indicates HFpEF is a predictor of mortality?

A

Mean pulmonary capillary wedge pressure > 15 mmHg at rest or 25 mmHg during exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is an early sign of LV failure and pulmonary HTN seen on CXR?

A

Distention of the pulmonary veins in the upper lung lobes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

_______ appears as a hilar haze with ill-defined margins

A

Perivascular edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

_____ produces a honeycomb pattern, reflecting interlobular edema

A

Kerley Lines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

________ produces densities in the lung fields, in a butterfly pattern

A

Alveolar edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Radiographic evidence of pulmonary edema can lag behind clinical evidence by up to ____ hrs

A

12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What does the ACC/AHA diagnostic criteria for HFpEF include?

A
  • HF symptoms
  • EF > 50%
  • Evidence of LVDD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

In contrast to AHA diagnosis critera, the European society of cardiology includes _______ evidence as another dx measurement

A

Echocardiographic evidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Which test (used alone) has a low predictive value for HF diagnosis/risk prediction?

A

Electrocardiogram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What role do brain natriuretic peptide (BNP) and N-terminal pro-BNP play in HF?

A

They are important biomarkers related to LV end-diastolic wall stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

LV end-diastolic wall stress is higher in which type of HF due to LV dilation and eccentric remodeling

A

HFrEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

HFpEF is associated with _______ hypertrophy, ______ LV chamber size, _______ LV end diastolic wall stress

A

Concentric hypertrophy
normal LV size
lower LV end diastolic wall stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Are BNP and NT-ProBNP levels higher in HFpEF or HFrEF?

A

Higher in HFrEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Myocardial damage increases which lab value?

A

Troponin (measures risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

What 2 labs represent the inflammatory component of HF?

A

C-Reactive Protein & Growth differentiation factor-15

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Which classification symptom focuses on degree of physical limiation?

A

NYHA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What classification system focuses on the presence and severity of HF?

A

ACC/AHA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Progression of HF is linked to a ______ ________ survival (the stages are progressive)

A

Reduced 5-year survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Survival has increased in _____ with treatment, while survival is unchanged with _____ patients

A

Increased survival in HFrEF
No change in HFpEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Which HF is medication ineffective for?

A

HFpEF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

What is a common treatment for HFrEF?

A
  • Beta-blockers
  • ACE-inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

This drug calss reduces LV filling pressures, decrease pulmonary venous congestion, and improve HF symptoms

A

Diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What is the mainstay tx for HFrEF that only shows benefits in HFpEF patietns if they have HTN?

A

ACE-i and ARBs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

This drug is useful in poorly controlled HTN pts to prevent HFpEF

A

Thiazide diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What is recommended for the treatment of HFpEF?

A
  • Mitigation of symptoms
  • Treatment of associated conditions
  • Exercise
  • Weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What diet is recommended to improve LV diastolic function, decrease arterial stiffness, and facilitate LV-arterial coupling in HFpEF patients?

A

DASH diet (Salt-restricted Dietary Approaches to Stop Hypertension)

65
Q

The goal of surgical treatment for chronic HF is to ____________ and preserve the natural heart geometry

A

prevent ventricular remodeling

66
Q

What is cardiac resynchronization therapy (CRT)?

A

A treatment for HF with a ventricular conduction delay (prolonged QRS) using biventricular pacing
-Stimulates the heart to contract more synchronously
-Goal: Improve CO

67
Q

This surgical treatment is done via CABG or PCI and can reverse LV dysfunction after MI to prevent permanent EF reduction

A

Coronary Revascularization

68
Q

What are the risks associated with CRT?

A
  • Infection
  • Misplacement
  • Device failure
69
Q

CRT is recommended for patients with EF < ______ and QRS duration ______ ms

A

EF < 35%
QRS 120-150 ms

70
Q

CRT can produce these outcomes

A
  1. Better exercise tolerance
  2. Improved ventricular function
  3. Less hospitalization
  4. Decreased mortality
71
Q

_______ allows for remote observation of intracardiac pressures to guide treatment

A

Implantable hemodynamic monitoring

72
Q

What % of deaths are due to sudden cardiac dysrhythmias?

73
Q

What device is used for preventing sudden death in advanced heart failure?

A

Implantable cardioverting-defibrillators (ICDs)

74
Q

Patients in the terminal stage of HF can benefit from mechanical circulatory support from a ______ that take over the function of the damaged ventricle and restore perfusion

75
Q

What is the purpose of LV assist devices?

A
  • Temporary ventricular assistance while heart is recovering
  • Patients awaiting cardiac transplant
  • Patients on inotropes or balloon pump with reversible conditions
76
Q

What characterizes acute heart failure?
Treatment?

A

Rapid onset, often presenting with life-threatening conditions
Treatment: Decrease volume & stabilize hemodynamics

77
Q

Acute HF that refers to those with exacerbated preexisting HF

A

Acute decompensated HF (ADHF)

78
Q

Initial onset HF is referred to

A

de novo Acute HF

79
Q

_______ is characterized by sudden increase in filling pressures or acute myocardial dysfunction leading to decreased perfusion and pulmonary edema
Symptoms: (3)

A

de novo AHF
Sx: Fluid retention, Weight gain, Dyspnea

80
Q

This is the leading cause of de novo HF; treatment focuses on restoring cardiac perfusion, improving contractility, and stabilizing HD

A

Cardiac ischemia

81
Q

Non-ischemic causes of de-novo HF are (3)

A
  1. Viral
  2. Drug-induced
  3. Peripartum cardiomyopathy
82
Q

Classic presentation of a ADHF patient presenting for urgent surgery have this HD profile
____ CO
____ Filling pressure
____ BP

A

Low CP
High Filling pressure
HTN or HoTN

83
Q

What is the first line treatment for acute heart failure?

A

Diuretics (Furosemide, Bumetenide, Torsemide as bolus or continuous gtt)

84
Q

If your AHF pt is hypotensive, what do you need to do before diuretic therapy?

A

Hemodynamic support

85
Q

Drugs that reduce filling pressures and afterload

A

Vasodilators

86
Q

Drug effective for rapidly decreasing afterload

A

Sodium nitroprusside

87
Q

Drug commonly used as an adjunct to diuretic therapy

88
Q

Drug is a potential adjunct to reduce the arterial constriction, hyponatremia and volume overload associated w/ AHF

A

Vasopressin receptor antagonists

89
Q

What is the mainstay treatment for patients with acute reduced contractility or cardiogenic shock?

A

Positive inotropes (epinephrine, norepinephrine, dopamine, dobutamine)

90
Q

Drug class inhibiting cAMP degredation increasing intracellular Ca++ and excitation/contraction coupling

A

PDE inhibitors (Milrinone)

91
Q

What is a exogenous BNP drug, inhibiting RAAS to decrease LVEDP and improve dyspena

A

Nesiritide

92
Q

What is the function of the intraaortic balloon pump?

A

Improves LV coronary perfusion by reducing LVEDP

93
Q

The balloon pump inflates _____ aortic valve closure and _____ during systole

A

Inflates after aortic valve closure
Deflates during systole

94
Q

IABP setting for full support?
Setting for tachycardic patients?

A

Full support: 1:1
Tachycardia: 1:2 (1 inflation/2 beats)

95
Q

How much does the IABP improve COP?

A

0.5-1 L/min (modest)

96
Q

What is the purpose of Impella?

A

Reduces LV strain and myocardial work
-Used up to 14 days as a bridge for cardiac procedure

97
Q

This type of VAD is a support device providing ECMO
Downside: Generates heat, causes hemolysis and lower flows

A

Peripheral VAD

98
Q

This VAD is an alternative to peripheral VAD but invasive and requires sternotomy/thoracotomy for placement
Benefits: Complete ventricular decompression, avoidance of limb impairments, avoidance of SVC syndrome

A

Central VAD/ECMO

99
Q

Impella VAD draws blood from the ____ and ejects it into the ______

A

LV and ejects into the ascending aorta

100
Q

What is ECMO used for?

A

Cardiorespiratory support or an alternative to peripheral VAD

101
Q

Patients on ECMO have _____ lung perfusion as blood bypasses the lungs before returning to the aorta

A

Redcued lung perfusion

102
Q

______ might be limited by functional shunting around the lungs
_____ is preferred in patients on ECMO

A

Inhaled anesthetics limited
TIVA is preferred

103
Q

ECMO membrane is ______ causing drugs like ______ to be sequestered within the circuit

A

Lipophilic; Fentanyl

104
Q

What does a biventricular assist device (BiVAD) do?

A

Once a patient on ECMO is stable, decoupling support of the ventricles facilitates weaning of the left- or right-sided support
-Percutaneous placement to support both sides

105
Q

What are HF patients at increased risk for during surgery?

A
  • Renal failure
  • Sepsis
  • Pneumonia
  • Cardiac arrest
    -Require longer periods of ventilation, increased 30-day mortality
106
Q

Postpone surgery in patients who are experiencing: (3)

A
  1. decompensation
  2. Recent change in clinical status
  3. de novo acute HF
107
Q

What is a Biventricular assist device (BiVAD)?

A

A device that supports both ventricles using separate circuits

It facilitates weaning of left- or right-sided support once a patient on central ECMO is stable.

108
Q

What medications should generally be held on the day of surgery for heart failure patients?
What drug is essential to maintain?

A

Diuretics
Beta blockers

Beta-blocker maintenance is essential.

109
Q

What test is indicated pre-op in a patient with worsening dyspena?

A

TTE (Transthroacic echocardiogram)

110
Q

What labs are taken in pre-op for HF patients
What lab is not routinely recommended

A

CBC, electrolytes, liver function, coagulation studies
BNP is not recommended

111
Q

What is cardiomyopathy?

A

Cardiac disease associated with mechanical and/or electrical dysfunction
-Often with ventricular hypertrophy or dilation
-Either confined to the heart or part of systemic disorders

Often includes ventricular hypertrophy or dilation.

112
Q

What are the two groups of cardiomyopathies?

A
  • Primary cardiomyopathies: confined to heart muscle
  • Secondary cardiomyopathies: pathologic cardiac involvement associated with multiorgan disorder
113
Q

What characterizes Hypertrophic Cardiomyopathy (HCM)?

A

Left ventricular hypertrophy (LVH) in absence of other diseases
-Presents with hypertrophy of the interventricular septum and anterolateral free wall

It is the most common genetic cardiovascular disease.

114
Q

What is the most common genetic CV disease?

A

Hypertrophic Cardiomyopathy

115
Q

Pathophyisology of HCM?
______ relaxtion time and _____ compliance

A

Patho: LVOT obstruction, mitral regurgitation, diastolic dysfunction, myocardial ischemia, dysrhythmia
-Prolonged relaxation time and decreased compliance

116
Q

What is the cause of sudden death in young patients with HCM?

A

Dysrhythmias

117
Q

Dysrhythmias are caused by: (3)

A
  1. Disorganized cell architecture
  2. Myocardial scarring
  3. expanded interstitial matrix
118
Q

What are common EKG abnormalities seen in 75-90% of HCM?

A
  • High QRS voltage
  • ST-segment and T-wave alterations
  • Abnormal Q waves
  • Left atrial enlargement
119
Q

In asymptomatic patients, unexplained ____ may be the only sign of HCM

A

Unexplained LVH

120
Q

In HCM:
Echocardiogram may show myocardial wall thickness > ____ mm

EF is usually > ___%, reflecting hypercontractility

A

wall thickness > 15 mm
EF > 80%

121
Q

What is the medical treatment for HCM?

A
  • Beta-blockers (BBs)
  • Calcium channel blockers (CCBs)
    HF despite BB and CCB:
  • Diuretics for heart failure
  • Disopyramide as add-on therapy
122
Q

Negative inotrope improving LVPOT obstruction and HF symptoms

A

Disopyramide

123
Q

This intervention allows direct measurement of increased LVEDP

A

cardiac catheterization

124
Q

What rhythm often develops in HCM?

A

A-fib (associated with thromboembolism, HF, and sudden death)

125
Q

What is the most effective antidysrhythmic in HCM patients

A

Amiodarone

126
Q

What is the primary surgical treatment for patients at risk of sudden cardiac death due to dysrhythmias in HCM?

A

ICD placement

It is reserved for patients with large outflow tract gradients and severe symptoms.

127
Q

HCM patients with large outflow tract gradients and severe symptoms are candidates for

128
Q

What surgical options are there for HCM?

A
  1. Septal myomectomy
  2. Cath w/ injection to induce ischemia of the septal perforator arteries
  3. Echo guided percutaneous septal ablation
  4. prosthetic mitral valve
129
Q

What characterizes Dilated Cardiomyopathy (DCM)?

A
  1. Atrial and ventricular dilation
  2. decreased wall thickness
  3. systolic dysfunction

It is the principal indication for cardiac transplant.

130
Q

What is the initial symptoms of dilated cardiomyopathy?

A

HF and chest pain

131
Q

Ventricular dilation can lead to

A

mitral/tricuspid regurgitation

132
Q

What pathology is common in dilated CM patients?

A

Dysrhythmia, emboli, sudden death

133
Q

What is Stress Cardiomyopathy also known as?
Coronary arteries are ______

A

Apical ballooning syndrome - LV hypokinesis with ischemic EKG changes
Coronary arteries are patent
-Temporary disruption of LV contractility with the rest of the heart having normal contractility

It features left ventricular hypokinesis with ischemic EKG changes.

134
Q

Main cause and symptom of stress cardiomypoathy?

A

Chest pain, dyspnea
Main cause: Physical/emotional stress
Women>Men

135
Q

What is seen on echo of dilated cardiomyopathy patient?

A

Dilation of all 4 chambers (predominantly the LV)
Global Hypokinesis

136
Q

Treatment for dilated CM?

A

Similar to chronic HF
1. Anticoagulants

137
Q

EKG often shows what for Dilated CM?
Common dysrthythmias?

A

EKG: ST and T wave abnormalities, LBBB
Dysrhythmia: PVC and Afib

138
Q

What can decrease risk of sudden death for dilated CM?

A

prophylactic ICD placement

139
Q

What is the principal indication for cardiac transplant?

A

Dilated cardiomyopathy

140
Q

Peripartum cardiomyopathy arises during which time period?

A

3rd trimester - 5 months postpartum

141
Q

What are the criteria for diagnosing Peripartum Cardiomyopathy?

A
  • Development of peripartum heart failure
  • Absence of another explainable cause
  • Left ventricular systolic dysfunction with EF <45%
142
Q

Cardiomyopathy caused by diseases leading to myocardial infiltration and diastolic dysfunction

A

Secondary Cardiomyopathy

143
Q

Sx of secondary cardiomyopathy?

A

HF without cardiomegaly/systolic dysfunction

144
Q

What does BP look like for secondary cardiomyopathy?

A

Low to normal BP + orthostatic hypotension

145
Q

What is Cor Pulmonale?

A

Right ventricular enlargement that may progress to right heart failure

It is commonly caused by pulmonary hypertension.

146
Q

What are the common causes of secondary cardiomyopathy?

A
  • Amyloidosis (most common)
  • Hemochromatosis
  • Sarcoidosis
  • Carcinoid tumors
147
Q

Causes of cor Pulmonale?

A

Most common: COPD
Other: pulmonary hypertension, heart disease, or significant respiratory, connective tissue, or chronic thromboembolic disease

148
Q

EKG changes of cor Pulmonale?

A

RA and RV hypertrophy
RA hypertrophy (Peaked P waves)
Right axis deviation and RBBB

149
Q

What is the most important determinant of pulmonary hypertension and cor pulmonale in patients with chronic lung disease?

A

Alveolar hypoxia

It is a key factor in the development of cor pulmonale.

150
Q

True or False: Hypertrophic cardiomyopathy is related to the development of left ventricular outflow tract (LVOT) obstruction.

151
Q

Fill in the blank: The initial symptom of Dilated Cardiomyopathy is _______.

A

heart failure

152
Q

What is the typical treatment for acute heart failure?

A
  • Loop diuretics
  • Vasodilators
  • Positive inotropes
  • Mechanical devices
153
Q

commonly d/t obstructive ischemic heart disease

154
Q

increasing in prevalence and primarily the result of poor lifestyle choices and comorbidities

155
Q

the most common genetic cardiac disorder. Its pathophysiology is related to the development of LVOT obstruction and ventricular dysrhythmias that can cause sudden death

156
Q

Factors that induce LVOT obstruction in HCM

A

hypovolemia, tachycardia,increased contractility, and decreased afterload

157
Q

the most common form of cardiomyopathy and the second most common cause of heart failure

A

Dilated CM

158
Q

The best treatment of alveolar hypoxia is

A

long-term oxygen therapy